Stocktoria
Passage BIO, Inc. PASG
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-02-28
Passage BIO, Inc. statistics & valuation
Market cap$15.1M
P / B0.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -73.1% | -63.2% | -67.8% | -55.9% | -52.2% |
| Return on equity | -242.7% | -105.7% | -91.7% | -67.6% | -58.2% |
| Current ratio | 2.07 | 4.07 | 7.22 | 10.74 | 11.02 |
Source: SEC EDGAR filings · CIK 0001787297 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.